We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. Allarity Therapeutics Inc is a clinical-stage, precision medicine company.
- Conversions Eliminate All Variable Priced Derivative Securities - Conversions Eliminate Any Market Overhang from Warrants - Series A Preferred and Warrant Conversions were Investor Initiated...
- Stockholders’ equity significantly surpasses the $2.5 million minimum required by Nasdaq - Company is to seek Nasdaq’s formal confirmation of compliance with equity requirements under the...
Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today...
Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.2508 | -74.0394736842 | 3.04 | 3.46 | 0.71 | 27142440 | 1.11953694 | CS |
4 | -2.4208 | -75.4143302181 | 3.21 | 4 | 0.71 | 8340900 | 1.27403288 | CS |
12 | -7.2108 | -90.135 | 8 | 8.8 | 0.71 | 3256184 | 1.70526879 | CS |
26 | -9.1108 | -92.0282828283 | 9.9 | 22.2 | 0.71 | 2276088 | 4.85454171 | CS |
52 | -13445.6108 | -99.9941307711 | 13446.4 | 14656 | 0.71 | 1683893 | 1427.47260696 | CS |
156 | 2220701.46045 | -100.000035538 | -2220700.67125 | 123520 | -1484398.55187 | 1523980 | -19318.4087147 | CS |
260 | 2220701.46045 | -100.000035538 | -2220700.67125 | 123520 | -1484398.55187 | 1523980 | -19318.4087147 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions